Multi-center phase II trial of temsirolimus (TEM) and bevacizumab (BEV) in pancreatic neuroendocrine tumor (PNET): Results of a planned interim efficacy analysis Meeting Abstract
| Authors: | Hobday, T.; Qin, R.; Reidy, D.; Moore, M.; Strosberg, J.; Kaubisch, A.; Shah, M.; Kindler, H.; Lenz, H. J.; Chen, H.; Erlichman, C. |
| Abstract Title: | Multi-center phase II trial of temsirolimus (TEM) and bevacizumab (BEV) in pancreatic neuroendocrine tumor (PNET): Results of a planned interim efficacy analysis |
| Meeting Title: | 5th Annual Meeting of the North American NeuroEndocrine Tumor Society |
| Journal Title: | Pancreas |
| Volume: | 42 |
| Issue: | 2 |
| Meeting Dates: | 2012 Oct 11-13 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0885-3177 |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2013-01-01 |
| Start Page: | 375 |
| End Page: | 376 |
| Language: | English |
| ACCESSION: | WOS:000314975200059 |
| PROVIDER: | wos |
| Notes: | --- - Meeting Abstract - "Source: Wos" |
MSK Authors
-
294Reidy